Local pharmacists said current tariff policies will make drugs more expensive and harder to find for consumers.

Bayer Pharmaceuticals' chief operating officer said the head of the top U.S. drug regulator recently reassured industry ...

Americans spend more on prescription and over-the-counter drugs than anyone else in the world. It’s true that they take a lot ...

Would the Trump administration's recently proposed drug pricing reforms hurt the biotech sector more than pharma? Seeking ...

Last year, Pirelli showed off its first 5G-connected Cyber Tyre. This year, it's taking that connectivity a step further.

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...

Is there anyone who thinks prescription drug prices in America are about right? President Trump has elevated an issue ...

If President Trump's threat to impose tariffs on pharmaceutical products goes through, it would have severe consequences for ...

We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...